Since highly effective immunotherapies have become available for multiple sclerosis (MS), many doctors have been wondering when – and with which vaccine – they should vaccinate patients. As a result, the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and the European Academy of Neurology (EAN) have created ...